About Contact Us Careers
Sign In

Cell Counting Market Size & Share, by Product (Instruments, Spectrophotometers, Flow Cytometers, Hemocytometers, Reagents, Microplates); End-user (Pharmaceutical Companies, Hospitals, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3546
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Cell Counting Landscape

top-features-companies
    • Merck KgaA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • Perkin Elmer Inc.
    • Olympus Corporation
    • Tecan Trading AG
    • Abbott Laboratories
    • General Electric Company
    • Boule Diagnostics AB
    • Becton, Dickinson, and Company
    • Sysmex Corporation
Browse Key Market Insights with Data Illustration:

In the News

  • Becton, Dickinson, and Company introduced BD FACSymphony A1 Cell Analyzer, which provides labs of all sizes access to powerful flow cytometry capabilities. Further, it is a fluorescence-activated cell analyzer that provides cutting-edge research capabilities in a small-footprint design, making it easier for more labs to obtain instruments for difficult scientific research.

  • Sysmex Corporation, a leading diagnostic solutions provider, received FDA approval for residual white blood cell counts, which will be added to its XN-10 Automated Hematology Analyzer with Blood Bank mode. Further, this analyzer offers residual white blood cell counts, red blood cell (RBC), and platelet (PLT) component testing in a single sample aspiration.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3546
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing prevalence of infectious diseases, and surging incidences of target diseases such as HIV are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2023-2035.

Exorbitant cost of cell analysis, and lack of knowledge are estimated to be the growth-hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Merck KgaA, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Olympus Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, end-user, and by region.

The research institutes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying